Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB011 topical DNAzyme in mild to moderate atopic eczema
2013-001091-38Phase 2Completed
- Sponsor
- sterna biologicals
- Start
- Oct 2013
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing SB011 topical formulation with Vehicle control (2 arms). Primary endpoint: Change from baseline in modified local SCORAD on Day 15. Started Oct 2013; status: completed.
02
Drugs
SB011
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2013-001091-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001091-38.